Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Stadhouders

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
ERJ Open Research|February 20, 2024
A new variant in the <i>ZCCHC8</i> gene: diverse clinical phenotypes and expression in the lungKarlijn Groen, Joanne J van der Vis, Aernoud A van Batenburg, et al.
European Journal of Epidemiology|March 21, 2023
Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trialGrigory Sidorenkov, Ralph Stadhouders, Colin Jacobs, et al.
Journal for Immunotherapy of Cancer|July 22, 2020
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine modelSai Ping Lau, Nadine van Montfoort, Priscilla Kinderman, et al.
Nature Cell Biology|July 30, 2021
CTCF chromatin residence time controls three-dimensional genome organization, gene expression and DNA methylation in pluripotent cellsWidia Soochit, Frank Sleutels, Gregoire Stik, et al.
Science Immunology|May 19, 2023
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistanceMandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters, et al.
Cell|March 12, 2017
Systemic Human ILC Precursors Provide a Substrate for Tissue ILC DifferentiationAi Ing Lim, Yan Li, Silvia Lopez-Lastra, et al.
Cancer Cell|October 2, 2020
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph NodesFloris Dammeijer, Mandy van Gulijk, Evalyn E Mulder, et al.
Science Immunology|January 30, 2021
Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseasesEsmee K van der Ploeg, Korneliusz Golebski, Menno van Nimwegen, et al.
Nature Communications|November 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancerSongul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
ERJ Open Research|February 20, 2024
A new variant in the <i>ZCCHC8</i> gene: diverse clinical phenotypes and expression in the lungKarlijn Groen, Joanne J van der Vis, Aernoud A van Batenburg, et al.
European Journal of Epidemiology|March 21, 2023
Multi-source data approach for personalized outcome prediction in lung cancer screening: update from the NELSON trialGrigory Sidorenkov, Ralph Stadhouders, Colin Jacobs, et al.
Journal for Immunotherapy of Cancer|July 22, 2020
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine modelSai Ping Lau, Nadine van Montfoort, Priscilla Kinderman, et al.
Nature Cell Biology|July 30, 2021
CTCF chromatin residence time controls three-dimensional genome organization, gene expression and DNA methylation in pluripotent cellsWidia Soochit, Frank Sleutels, Gregoire Stik, et al.
Science Immunology|May 19, 2023
PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistanceMandy van Gulijk, Anneloes van Krimpen, Sjoerd Schetters, et al.
Cell|March 12, 2017
Systemic Human ILC Precursors Provide a Substrate for Tissue ILC DifferentiationAi Ing Lim, Yan Li, Silvia Lopez-Lastra, et al.
Cancer Cell|October 2, 2020
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph NodesFloris Dammeijer, Mandy van Gulijk, Evalyn E Mulder, et al.
Science Immunology|January 30, 2021
Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseasesEsmee K van der Ploeg, Korneliusz Golebski, Menno van Nimwegen, et al.
Nature Communications|November 28, 2025
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancerSongul Kucukcelebi, Freek R van 't Land, Sjoerd H van der Burg, et al.
Pageof 8